Harm Reduction Journal
March 29, 2026
Piotr Siuda, Paweł Matuszewski
Abstract Background Determining health information quality on online drug platforms is crucial for revealing and shaping substance use practices. The study aims to assess the scope and quality of health-related information on the largest Polish drug forum, Hyperreal. Ultimately, the goal was to explore how the case of Hyperreal illustrates user-driven knowledge construction around drug use and...
Harm Reduction Journal
March 2, 2026
Cianna J Piercey, Joseph Cameron, Riley Ahern et al.
Kratom is a psychoactive botanical that is increasingly popular in the United States. While potential risks of kratom use have been identified, research on harm reduction strategies and contextual factors contributing to adverse reactions is limited. Given that kratom is federally unregulated at present, and a variety of kratom products are widely available on the commercial market, more data...
Harm Reduction Journal
February 14, 2026
Camilo Obregón-berg, Bruno Fuentealba-Donoso, Isidora Vidal et al.
The health risks for people who use drugs (PWUD) in Chile are exacerbated by evolving drug markets, unpredictable supplies, and the limited availability of harm reduction services. Community-based drug-checking programs have shown effectiveness in reducing some of these risks; however, regional evidence remains limited. In 2024, Reduciendo Daño (RD), a Chilean non-profit organization, conducted...
Harm Reduction Journal
February 6, 2026
Keaton Hudson-Buhagiar, Jonathan Brett, Alanah Spillane et al.
1 citation
Harms associated with gamma-hydroxybutyrate (GHB) use have increased recently in Australia. However, research predominantly focuses on the experience of GHB use among LGBTQ + populations. Non-prescribed GHB use has not been well described in heterosexual populations. Research to examine the experience of heterosexual people, including motivations for use, experiences of harms, and utilisation...
Harm Reduction Journal
December 8, 2025
Kenny Kor, Julaine Allan, J. Cameron et al.
Nitrous oxide (N2O), colloquially known as “laughing gas”, is a dissociative anaesthetic that has become increasingly popular among young people as a recreational drug. Social media and messaging platforms have made N2O more accessible. As avid users of social media, young people are well-positioned to contribute to the development of digitalised harm reduction resources. This study draws on...
Harm Reduction Journal
September 29, 2025
Yen-Chun Kuo, Sheng-Chang Wang, Chuan-Yu Chen
The misuse of ketamine, a dissociative anesthetic, has surged sharply in popularity across East and Southeast Asia and Oceania. This study aimed to evaluate the association between recent patterns of ketamine use and the risk of suicide in northern Taiwan. Illicit ketamine users were recruited through network-based sampling from 2015 to 2017, along with a comparison group of individuals who...
Harm Reduction Journal
November 5, 2024
Chris Wilkins, Jose Romeo, Marta Rychert et al.
8 citations
The substitution of cannabis for alcohol and other drugs has been conceptualised in a harm reduction framework as where cannabis is used to reduce the negative side-effects, addiction potential, and social stigma of other drugs. There is currently mixed evidence with recent reviews suggesting cannabis co-use patterns may vary by age and ethnicity. Yet few studies have had large enough samples...
Harm Reduction Journal
October 18, 2024
Nicolas Fabresse, Eurydice Papias, Alma Heckenroth et al.
3 citations
The increasing diversity of psychoactive substances on the unregulated drug market poses significant health, psychological, and social risks to people who use drugs (PWUD). To address these risks, various harm reduction (HR) policies have been implemented, including drug checking services (DCS). Many analytical methods are used for DCS. While qualitative methods (e.g., thin layer...
Harm Reduction Journal
May 23, 2024
Jai Whelan, Ryan D Ward, Geoff Noller
2 citations
Methylenedioxymethamphetamine (MDMA) is a popular drug worldwide and use is prevalent in Aotearoa New Zealand. Although associated with some significant harms, including fatalities, MDMA is ultimately less harmful than other commonly consumed drugs. We aimed to expand the understanding of MDMA harm and harm reduction strategies from a consumer perspective so that national harm reduction efforts...
Harm Reduction Journal
March 21, 2024
Jai Whelan, Geoff Noller, Ryan D Ward
6 citations
3,4-Methylenedioxymethamphetamine (MDMA) is drug of high prevalence in Aotearoa New Zealand and is the primary drug analysed by legal drug checking services. We aimed to address the gap in literature pertaining to MDMA-related harm reduction behaviour and harm experiences within the country. An online survey was used to assess the harm reduction behaviours (e.g., limiting consumption, planning...
Harm Reduction Journal
December 10, 2023
Silvia L. Cruz, Miguel Bencomo-Cruz, María E. Medina-Mora et al.
10 citations
Abstract Background Perception of drug adulteration has increased in Mexico, but there is little research on adulterants and toxicity. The aim of this study was to identify drug composition in an electronic music outdoor festival nearby Mexico City. Methods The participants completed a questionnaire with demographic data, harm reduction strategies, drug-use patterns, history, and the drug they...
Harm Reduction Journal
December 6, 2023
Yula Milshteyn, Moshe Bensimon
8 citations
Rave music parties (RMP) are a world-wide socio-cultural phenomenon, where people listen to rave music while frequently consuming psychedelic drugs. Epidemiological studies have emphasized the hazardous consequences following the consumption of psychedelic drugs at RMP, and qualitative studies have shown social and psycho-spiritual experiences. Yet, phenomenological inquiry into subjective...
Harm Reduction Journal
August 9, 2023
Hagit Bonny-Noach, Barak Shapira, Pinchas Baumol et al.
9 citations
Few studies have analyzed harm reduction behaviors and attitudes among rave party attendees. Since the late 1980s, there has been a large Israeli rave scene, also known as 'Nature Parties'. However, only a few studies have been conducted among nature party attendees and almost all of them are from a qualitative perspective. This study's aim was to fill the gap and conduct quantitative research...
Harm Reduction Journal
July 28, 2023
Théo Willeman, Nathan Grundig, Christine Pochon et al.
8 citations
3-methylmethcathinone (3-MMC) has been available on the European drug market for several years, but an increase in its availability seems to have occurred around 2020, associated with reports of harm and death. We aimed to analyze the composition of the supposed 3-MMC samples purchased and its concordance with the assumed composition of the drug. A prospective multicenter (n = 6) study was...
Harm Reduction Journal
July 24, 2022
Madelene Palmer, Olivia Maynard
29 citations
BACKGROUND: Alongside a recent revival in the use of psychedelics in clinical settings, there have been increases in the prevalence of recreational use, with many using psychedelics to deal with difficult emotions or to improve well-being. While clinical research is conducted in carefully controlled settings, this is not necessarily the case for recreational use. In this mixed methods online...
Harm Reduction Journal
February 5, 2022
Joseph J Palamar, İbrahim Sönmez
Dance festivals have been shown to be high-risk events for use of drugs such as ecstasy/MDMA and possible adverse effects associated with use. However, few studies have examined what makes festivals such risky environments. We aimed to determine festival-specific risk factors for adverse outcomes related to drug use. In-depth interviews were conducted with 35 key informants in North America who...
Harm Reduction Journal
April 11, 2021
Brian Pilecki, Jason B. Luoma, Geoff J. Bathje et al.
135 citations
Abstract Psychedelic-assisted therapy may represent an upcoming paradigm shift in the treatment of mental health problems as recent clinical trials have demonstrated strong evidence of their therapeutic benefits. While psychedelics are currently prohibited substances in most countries, the growing popularity of their therapeutic potential is leading many people to use psychedelics on their own...
Harm Reduction Journal
November 28, 2019
Martin Andersson, Anette Kjellgren
35 citations
Abstract Background Psychedelic microdosing is the trending practice of using tiny repeated doses of psychedelic substances to facilitate a range of supposed benefits. With only a few published studies to date, the subject is still under-researched, and more knowledge is warranted. Social media and internet discussion forums have played a vital role in the growing visibility of the microdosing...
Harm Reduction Journal
July 9, 2019
Thomas Anderson, Rotem Petranker, Adam Christopher et al.
130 citations
These mixed-methods results help summarize and frame the experiences reported by an active microdosing community as high-potential avenues for future scientific research. The MDBC taxonomy reported here informs future research, leveraging participant reports to distil the highest-potential intervention targets so research funding can be efficiently allocated. Microdosing research complements...
Harm Reduction Journal
September 4, 2017
Martin Andersson, Mari Persson, Anette Kjellgren
93 citations
BACKGROUND: Treatment resistant cluster headache and migraine patients are exploring alternative treatments online. The aim of this study was to improve comprehension regarding the use of non-established or alternative pharmacological treatments used by sufferers of cluster headaches and migraines. METHODS: A qualitative thematic analysis of the users' own accounts presented in online forum...
Harm Reduction Journal
2013
Levente Móró, József Rácz
82 citations
Harm reduction has been increasingly finding its way into public drug policies and healthcare practices worldwide, with successful intervention measures justifiably focussing on the highest-risk groups, such as injecting drug users. However, there are also other types of drug users in need for harm reduction, even though they pose less, low, or no public health risk. Occasionally, drug users...
Harm Reduction Journal
2007
Rachael Butler, Janie Sheridan
78 citations
BACKGROUND: This study aimed to investigate patterns and context of use of BZP-party pills, function of use, and positive and negative effects experienced by a sample of New Zealand young people who had used the products. METHODS: A qualitative study comprised of semi-structured interviews and group discussions. RESULTS: The sample included 58 young people aged 17-23 years who had used...